Filing Flows › Comparisons › TXG vs PACB
10x Genomics vs Pacific Biosciences of California: TXG and PACB compared
10x Genomics is the larger company: $151M of revenue in its latest quarter (Q3 2026) against $40.6M for Pacific Biosciences of California (Q3 2026). Pacific Biosciences of California is growing faster (+6% against +1% a year earlier). 10x Genomics is more profitable, with an operating margin of -10.7% against -91.2%.
Where the money goes: TXG and PACB
10x Genomics (TXG) · Q3 2026
10x Genomics, Q3 2026: revenue $151M (+1% year over year), operating margin -10.7%, net loss $19.4M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
Pacific Biosciences of California (PACB) · Q3 2026
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart follows the revenue to costs, profit and cash.
| 10x Genomics (TXG) | Pacific Biosciences of California (PACB) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $151M | $40.6M |
| Revenue growth, Y/Y | +1% | +6% |
| Operating margin | -10.7% | -91.2% |
| Net earnings | −$19.4M | −$37.8M |
| Net margin | -12.9% | -93.3% |
| Operating cash flow | $15.8M | −$37.6M |
| Free cash flow | $14.9M | — |
Where the revenue comes from
10x Genomics
- Consumables: $134M (89%)
- Services: $9.0M (6%)
- Instruments: $6.9M (5%)
Pacific Biosciences of California
- Product revenue: $34.0M (84%)
- Service and other revenue: $6.6M (16%)
Questions
Which is bigger, 10x Genomics or Pacific Biosciences of California?
10x Genomics is the larger company: $151M of revenue in its latest quarter (Q3 2026) against $40.6M for Pacific Biosciences of California (Q3 2026).
Is 10x Genomics or Pacific Biosciences of California growing faster?
Pacific Biosciences of California is growing faster (+6% against +1% a year earlier).
Which is more profitable, 10x Genomics or Pacific Biosciences of California?
10x Genomics is more profitable, with an operating margin of -10.7% against -91.2%.
More: 10x Genomics earnings · how 10x Genomics makes money · Pacific Biosciences of California earnings · how Pacific Biosciences of California makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.